Zobrazeno 1 - 10
of 172
pro vyhledávání: '"Kate Young"'
Autor:
Lisa Zimmer, Bastian Schilling, Yinghong Wang, Georgina V Long, Jennifer McQuade, Ana Arance, Douglas B Johnson, Nadia Yousaf, Kazi J Nahar, Matteo S Carlino, Kate Young, Joanna Lee, Liselotte Tas, Serigne N Lo, Christian Blank, Alexander Maxwell Menzies, Catriona Harvey, Janet McKeown, Sheima Farag, Aafke Meerveld-Eggink, Austin Thomas, Roberto Martín Huertas
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 1 (2024)
Background Immune checkpoint inhibitor (ICI) gastrointestinal toxicity (gastritis, enteritis, colitis) is a major cause of morbidity and treatment-related death. Guidelines agree steroid-refractory cases warrant infliximab, however best management of
Externí odkaz:
https://doaj.org/article/fd4c46a2bc33417a85a04b53c7be5d49
Autor:
Suprateeka Talukder, Aruni Ghose, Turja Chakraborty, Anna Olsson-Brown, Sivatharshini Ramalingam, Stuart D. Rosen, Kate Young, Alexander R. Lyon, Arjun K. Ghosh
Publikováno v:
International Journal of Cardiology: Heart & Vasculature, Vol 49, Iss , Pp 101278- (2023)
Externí odkaz:
https://doaj.org/article/2f944c9b624940919b716b77086f64c7
Publikováno v:
Endocrine Connections, Vol 12, Iss 5, Pp 1-13 (2023)
Checkpoint inhibitors are now widely used in the management of many cancers. Endocrine toxicity is amongst the most common side effects. These endocrinopathies differ from most other immune-related toxicities in frequently being irreversible and rare
Externí odkaz:
https://doaj.org/article/4cd5b8b278ce47c8b11dc5765e692690
Autor:
Byron J. Gajewski, Bruce F. Kimler, Devin C. Koestler, Dinesh Pal Mudaranthakam, Kate Young, Carol J. Fabian
Publikováno v:
Trials, Vol 23, Iss 1, Pp 1-11 (2022)
Abstract Background Our randomized controlled clinical trial will explore the potential of bazedoxifene plus conjugated estrogen to modulate breast tissue-based risk biomarkers as a surrogate for breast cancer risk reduction. This paper investigates
Externí odkaz:
https://doaj.org/article/59ae739e2a94408fb0db46be8e21c1f5
Autor:
Kate Young, Andreas M. Schmitt, Deborah Mukherji, Lavinia Spain, Manuela Schmidinger, Lisa M. Pickering
Publikováno v:
Société Internationale d’Urologie Journal, Vol 3, Iss 6, Pp 485-499 (2022)
Standard approved systemic treatment options for the management of renal cancer have entirely transformed in the last 15 years and now comprise molecularly targeted therapies against the vascular endothelial growth factor receptor (VEGFR) and the mam
Externí odkaz:
https://doaj.org/article/ee3043a63966443897daa5d94dbede12
Autor:
Maria Sol Andres, Sivatharshini Ramalingam, Stuart D. Rosen, John Baksi, Rajdeep Khattar, Yulia Kirichenko, Kate Young, Nadia Yousaf, Alicia Okines, Robert Huddart, Kevin Harrington, Andrew J.S. Furness, Samra Turajlic, Lisa Pickering, Sanjay Popat, James Larkin, Alexander R. Lyon
Publikováno v:
Cardio-Oncology, Vol 8, Iss 1, Pp 1-11 (2022)
Abstract Background The full range of cardiovascular complications related to the use of Immune checkpoint inhibitors (ICI) is not fully understood. We aim to describe the spectrum of cardiovascular adverse events (cvAEs) by presenting our real-world
Externí odkaz:
https://doaj.org/article/fa4fded19f0f4ec18a9a3501d5922e32
Autor:
Pietro Carotenuto, Francesco Amato, Andrea Lampis, Colin Rae, Somaieh Hedayat, Maria C. Previdi, Domenico Zito, Maya Raj, Vincenza Guzzardo, Francesco Sclafani, Andrea Lanese, Claudia Parisi, Caterina Vicentini, Ian Said-Huntingford, Jens C. Hahne, Albert Hallsworth, Vladimir Kirkin, Kate Young, Ruwaida Begum, Andrew Wotherspoon, Kyriakos Kouvelakis, Sergio Xavier Azevedo, Vasiliki Michalarea, Rosie Upstill-Goddard, Sheela Rao, David Watkins, Naureen Starling, Anguraj Sadanandam, David K. Chang, Andrew V. Biankin, Nigel B. Jamieson, Aldo Scarpa, David Cunningham, Ian Chau, Paul Workman, Matteo Fassan, Nicola Valeri, Chiara Braconi
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-14 (2021)
Understanding which patients will respond to FOLFIRINOX therapy is important for clinical outcome. Here, the authors show that the MIR1307 is increased pancreatic cancer cell lines and inhibition of the microRNA sensitises cells to treatment.’ stra
Externí odkaz:
https://doaj.org/article/a029501cd4ea4989bf6d137ae286835e
Publikováno v:
Journal of Primary Health Care, Vol 12, Iss 3, Pp 265-271 (2020)
ABSTRACT INTRODUCTIONScreening tools assist primary care clinicians to identify mental health, addiction and family violence problems. Electronic tools have many advantages, but there are none yet available in the perinatal context. AIMTo assess the
Externí odkaz:
https://doaj.org/article/3769b2e91955485c86e5672147eb57cb
Autor:
Kate Young
Publikováno v:
International Journal of Medical Students, Vol 9, Iss 1 (2021)
Primary care physicians (PCP’s) are patient’s first line of defense against any medical and social ailment. If patients can relate to and trust their PCP beyond the framework of their disease, they ‘stick’ with that doctor for life and bring
Externí odkaz:
https://doaj.org/article/c256b14700b147d1a644653d6da6dd65
Publikováno v:
International Journal of Qualitative Methods, Vol 19 (2020)
For most children and adolescents diagnosed with a brain tumor, whether malignant or not, there will be an irrevocably negative impact on their life and that of their family. In Australia, 5 year disease-free survival is 76% meaning that many young p
Externí odkaz:
https://doaj.org/article/f8ebbee2e15d43129d53b98be1e047c8